Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media
Study Details
Study Description
Brief Summary
This is a randomized, controlled, single-center study in otherwise healthy infertile female subjects undergoing in vitro fertilization (IVF). The subjects recruited for this study will be among those patients who have been diagnosed with infertility and are planning to undergo IVF at the centers where this study is being performed. The patients will have undergone the usual informed consent procedure at the center.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Subjects will undergo ovarian stimulation, oocyte retrieval, IVF, and Intra Cytoplasmic Sperm Injection (ICSI) procedure following the center's usual procedures. The cohort of injected oocytes from each patient will be randomly divided between the one step and sequential medias: CRM (Cornell- Center for Reproductive Medicine) media (C1/C2 or C3) vs G-TL Time Lapse media or G-1/G-2 media. Single step or sequential media are both buffered mediums for culture from oocyte fertilization to blastocyst stage. Sequential media is formulated according to the stages of embryo development and embryos are re-cultured in medias according to their stage of development. Single step (time lapse) media is formulated for continuous culture from D0 to Day 5/6.
Mature oocytes will be randomized via a non-bias computer program into two to four of the study groups: G-TL commercial single step (Vitrolife), Vitrolife's sequential media, Cornell's single step , and Cornell's sequential media. Oocytes will be divided randomly among the various media dependent upon the number of mature oocytes. I.e.: 10 oocytes injected = 2 media groups; 15 oocytes injected = up to 3 media groups; 20 oocytes injected = up to 4 media groups.
"Best grade" embryos will be transferred regardless of media source. If embryos are transferred from multi-source media and if researchers are unable to determine the media source after transfer, the subject will not be included in the outcome data portion of the study- e.g pregnancy outcome.
The Time-Lapse monitoring system will be used as standard clinical practice to observe development and document timing of embryo cleavages and morphology dynamics.
Endpoints will be Day 3 and Day 5/6 embryo development, implantation and pregnancy rate. The study is approximately 2 months, the estimated time it takes a physician to perform one IVF-ART IVF- Assisted Reproductive Technology) treatment cycle. If embryos are frozen, the patient may be in the study until the time they choose to thaw the embryos or up to 1 year if they become pregnant.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: CRM sequential media (C1/C2) CRM sequential media, formulated according to the stages of embryo development, is used to culture the embryos from oocyte fertilization to blastocyst stage. |
Other: embryo culture in buffered media
compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.
Other Names:
|
| Active Comparator: CRM single step media (C3) CRM single step media is used to culture the embryos from oocyte fertilization to blastocyst stage. |
Other: embryo culture in buffered media
compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.
Other Names:
|
| Experimental: Vitrolife media G1/2 Sequential Vitrolife sequential media, formulated according to the stages of embryo development, is used to culture the embryos from oocyte fertilization to blastocyst stage. |
Other: embryo culture in buffered media
compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.
Other Names:
|
| Experimental: Vitrolife G-TL Time Lapse media Single Step G-TL Time Lapse Single step (time lapse) media is formulated for continuous culture from oocyte fertilization to blastocyst stage. |
Other: embryo culture in buffered media
compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Embryo development [1 year]
Comparison of embryo development using standard assessments of morphokenetics of embryo development
Secondary Outcome Measures
- Embryo transfer rate [1 year]
Percentage of embryo transferred in each arm.
- Clinical pregnancy rates [within 3 months of embryo transfer]
Percentage of embryos transferred that implant into the uterus by evidence of a fetal sac by ultrasound
Other Outcome Measures
- Number of participants pregnant after Frozen Embryo Transfer [2 years]
Pregnancy rate from frozen embryo transfer in each arm.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
40 years of age or younger (maternal) 65 years of age or younger (paternal)
-
Patient must have 10 or greater than 10 mature oocytes, ICSI only
-
Fresh or frozen (including donor) sperm can be used. Fresh oocytes only (including donor)
-
Frozen embryos from this study can be included in the outcome portion of this study.
-
Single or double Blastocyst transfer only
Exclusion Criteria:
-
Patients having PGS (Pre-implantation Genetic Screening)
-
3 or more previous failed cycles
-
Sperm obtained by testicular biopsy
-
Previous enrollment in the study
-
Non blastocyst transfer
-
Co-culture patients
-
Outcome data portion exclusion only:
Multi-source media transfers if researchers are unable to determine the media source after transfer.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Center fo Reproductive Medicine | New York | New York | United States | 10021 |
Sponsors and Collaborators
- Weill Medical College of Cornell University
- Vitrolife
Investigators
- Principal Investigator: Nikica Zaninovic, PhD, Weill Medical College of Cornell University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 1411015635